Literature DB >> 19337283

A symptom-based approach to pharmacologic management of fibromyalgia.

Chad S Boomershine1, Leslie J Crofford.   

Abstract

Fibromyalgia is a prevalent disorder that is characterized by widespread pain along with numerous other symptoms, including fatigue, poor sleep, mood disorders, and stiffness. Previous guidelines for the management of fibromyalgia recommended an approach that integrates pharmacologic and nonpharmacologic therapies selected according to the symptoms experienced by individual patients. However, they offered no recommendations for a system of patient assessment that would provide a basis for individualized treatment selection. We present a simple, rapid and easily remembered system for symptom quantitation and pharmacologic management of fibromyalgia that combines visual analogue scale symptom scores from a modified form of the disease-neutral Fibromyalgia Impact Questionnaire, with a review of medications that can be used to treat the individual symptoms. This symptom-based approach is amenable to caring for patients with fibromyalgia in a busy clinical practice.

Entities:  

Mesh:

Year:  2009        PMID: 19337283     DOI: 10.1038/nrrheum.2009.25

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  56 in total

1.  Modafinil in fibromyalgia treatment.

Authors:  J L Schaller; D Behar
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

2.  Modafinil treatment for fatigue associated with fibromyalgia.

Authors:  Thomas L Schwartz; Sheetal Rayancha; Ayesha Rashid; Susan Chlebowksi; Mark Chilton; Martin Morell
Journal:  J Clin Rheumatol       Date:  2007-02       Impact factor: 3.517

3.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

Authors:  R Bennett
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

4.  An open-label study of quetiapine in the treatment of fibromyalgia.

Authors:  Javier Hidalgo; Fernando Rico-Villademoros; Elena Pita Calandre
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-08-04       Impact factor: 5.067

5.  Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample.

Authors:  Kevin P White; Warren R Nielson; Manfred Harth; Truls Ostbye; Mark Speechley
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

6.  Venlafaxine treatment of fibromyalgia.

Authors:  Kemal Sayar; Gokhan Aksu; Ismail Ak; Mehmet Tosun
Journal:  Ann Pharmacother       Date:  2003-11       Impact factor: 3.154

Review 7.  Choosing a skeletal muscle relaxant.

Authors:  Sharon See; Regina Ginzburg
Journal:  Am Fam Physician       Date:  2008-08-01       Impact factor: 3.292

8.  Sleep-promoting properties of quetiapine in healthy subjects.

Authors:  Stefan Cohrs; Andrea Rodenbeck; Zhenghua Guan; Kathrin Pohlmann; Wolfgang Jordan; Andreas Meier; Eckart Rüther
Journal:  Psychopharmacology (Berl)       Date:  2004-03-17       Impact factor: 4.530

9.  Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.

Authors:  Jon I Russell; Philip J Mease; Timothy R Smith; Daniel K Kajdasz; Madelaine M Wohlreich; Michael J Detke; Daniel J Walker; Amy S Chappell; Lesley M Arnold
Journal:  Pain       Date:  2008-04-18       Impact factor: 6.961

Review 10.  The significance, assessment, and management of nonrestorative sleep in fibromyalgia syndrome.

Authors:  Harvey Moldofsky
Journal:  CNS Spectr       Date:  2008-03       Impact factor: 3.790

View more
  22 in total

Review 1.  New directions in fibromyalgia.

Authors:  Deanna Davenport; Celso R Velázquez
Journal:  Mo Med       Date:  2012 Jan-Feb

Review 2.  Fibromyalgia: evolving concepts over the past 2 decades.

Authors:  Mary-Ann Fitzcharles; Peter A Ste-Marie; John X Pereira
Journal:  CMAJ       Date:  2013-05-06       Impact factor: 8.262

Review 3.  An overview of systematic reviews of complementary and alternative medicine for fibromyalgia.

Authors:  Rohini Terry; Rachel Perry; Edzard Ernst
Journal:  Clin Rheumatol       Date:  2011-05-26       Impact factor: 2.980

4.  Simplifying Fibromyalgia Assessment: The VASFIQ Brief Symptom Scale.

Authors:  Chad S Boomershine; Birol Emir; Yi Wang; Gergana Zlateva
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-10       Impact factor: 5.346

5.  The FIBRO System: A Rapid Strategy for Assessment and Management of Fibromyalgia Syndrome.

Authors:  Chad S Boomershine
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

6.  2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary.

Authors:  Mary-Ann Fitzcharles; Peter A Ste-Marie; Don L Goldenberg; John X Pereira; Susan Abbey; Manon Choinière; Gordon Ko; Dwight E Moulin; Pantelis Panopalis; Johanne Proulx; Yoram Shir
Journal:  Pain Res Manag       Date:  2013 May-Jun       Impact factor: 3.037

Review 7.  Fibromyalgia syndrome in need of effective treatments.

Authors:  Theoharis C Theoharides; Irene Tsilioni; Lauren Arbetman; Smaro Panagiotidou; Julia M Stewart; Rae M Gleason; Irwin J Russell
Journal:  J Pharmacol Exp Ther       Date:  2015-08-25       Impact factor: 4.030

Review 8.  Acupuncture for treating fibromyalgia.

Authors:  John C Deare; Zhen Zheng; Charlie C L Xue; Jian Ping Liu; Jingsheng Shang; Sean W Scott; Geoff Littlejohn
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

Review 9.  A framework for fibromyalgia management for primary care providers.

Authors:  Lesley M Arnold; Daniel J Clauw; L Jean Dunegan; Dennis C Turk
Journal:  Mayo Clin Proc       Date:  2012-05       Impact factor: 7.616

10.  Fibromyalgia: a new treatment option for fibromyalgia.

Authors:  Robert M Bennett
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.